Detection of soluble TRAIL in HBV infected patients and its clinical implications

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

223

HTML

2510

Tables (1-4)

197

Sum=2930

Dec 15, 2002 (publication date) through Nov 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Dec 15, 2002; 8(6): 1077-1080
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1077

Table 1 Statistical analysis of the relevance of expression of sTRAIL and clinical staging of hepatitis B

	n	sTRAIL( × 10^-9μg/mL)
HBV carriers	8	876.88 ± 369.59
Chronic hepatitis	30	1494.97 ± 533.24
Mild chronic hepatitis	9	1138.90 ± 424.90
Moderate chronic hepatitis	12	1558.65 ± 489.87^a
Severe chronic hepatitis	9	1812.78 ± 499.99^b
HBV infectious related cirrhosis	11	1375.00 ± 526.08^c
HBV related infectious liver cancer	3	1561.00 ± 449.56^d

^aP < 0.01 vs mild chronic hepatitis group;

^bP < 0.001 vs mild chronic hepatitis group;

^cP < 0.05 vs severe chronic hepatitis group;

^dP < 0.05 vs severe chronic hepatitis group

Citation: Han LH, Sun WS, Ma CH, Zhang LN, Liu SX, Zhang Q, Gao LF, Chen YH. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol 2002; 8(6): 1077-1080
URL: https://www.wjgnet.com/1007-9327/full/v8/i6/1077.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i6.1077